Jia et al enriched CD90+/CD133+ hepatocellular carcinoma CSCs using spheroid body formation and observed that OCT4 and ABCG2 were highly expressed in the enriched CD90+/CD133+ liver CSCs and were closely associated with chemotherapy drug resistance (27). The gene discussed is ABCG2; the disease is hepatocellular carcinoma.